Global Noninvasive Prenatal Testing Market Analysis, Trends, Segment & Forecast Up to 2020

Deerfield Beach, FL -- (SBWIRE) -- 04/29/2016 -- Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal diagnosis (NIPD). Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) or a sex chromosome irregularity, such as Turner syndrome. The testing can also be used to determine a baby's sex and rhesus (Rh) blood type. The Non-Invasive Prenatal Test (NIPT) is a DNA test on maternal blood to screen for the fetal aneuploidies (chromosomes 21, 18, 13) during pregnancy. Now, noninvasive prenatal testing is only available for women who have certain risk issue. Non-invasive prenatal testing (NIPT) offers harmony, verifi, Panorama, informaSeq, VisibiliT, PrenaTest, BambniTest and other test.